Baijiu plate strength, mouth cellar line exceeds 10%

Synthetic Biology: Who Will Emerge as the Winner?

The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.

Week's Go Global Information Gap (11/23–11/29): The US launched the AI "Genesis Project"

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

China and U.S. Agree to Pause Certain Tariffs and Export Restrictions

​On October 30, China’s Ministry of Commerce (商务部) officially released the outcomes of the China–U.S. trade consultations held in Kuala Lumpur. Building on the consensus reached during the China–U.S. presidential meeting in Busan, the two countries’ economic and trade teams achieved substantive breakthroughs on key issues such as tariffs and export controls, providing a strong boost of confidence to the global economy.

EqualOcean｜China's Top 20 ESG Performers Among Private Enterprises（Part III）

Private enterprises are actively embracing the transformative era

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.